448 related articles for article (PubMed ID: 19143013)
1. Factors affecting carbon dioxide laser treatment for oral precancer: a patient cohort study.
Hamadah O; Thomson PJ
Lasers Surg Med; 2009 Jan; 41(1):17-25. PubMed ID: 19143013
[TBL] [Abstract][Full Text] [Related]
2. Interventional laser surgery: an effective surgical and diagnostic tool in oral precancer management.
Thomson PJ; Wylie J
Int J Oral Maxillofac Surg; 2002 Apr; 31(2):145-53. PubMed ID: 12102411
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of outcome after transoral CO(2) laser resection of T1/T2 oral squamous cell carcinoma.
Jerjes W; Upile T; Hamdoon Z; Mosse CA; Akram S; Hopper C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Aug; 112(2):180-7. PubMed ID: 21232996
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment outcome of oral premalignant lesions.
Holmstrup P; Vedtofte P; Reibel J; Stoltze K
Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
[TBL] [Abstract][Full Text] [Related]
5. Predicting recurrence after oral precancer treatment: use of cell cycle analysis.
Thomson PJ; Hamadah O; Goodson ML; Cragg N; Booth C
Br J Oral Maxillofac Surg; 2008 Jul; 46(5):370-5. PubMed ID: 18282643
[TBL] [Abstract][Full Text] [Related]
6. Management of oral carcinoma: benefits of early precancerous intervention.
Goodson ML; Thomson PJ
Br J Oral Maxillofac Surg; 2011 Mar; 49(2):88-91. PubMed ID: 20678830
[TBL] [Abstract][Full Text] [Related]
7. Cancerisation within the oral cavity: the use of 'field mapping biopsies' in clinical management.
Thomson PJ; Hamadah O
Oral Oncol; 2007 Jan; 43(1):20-6. PubMed ID: 16757199
[TBL] [Abstract][Full Text] [Related]
8. Outcome of oral dysplasia: a retrospective hospital-based study of 207 patients with a long follow-up.
Arduino PG; Surace A; Carbone M; Elia A; Massolini G; Gandolfo S; Broccoletti R
J Oral Pathol Med; 2009 Jul; 38(6):540-4. PubMed ID: 19453839
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
[TBL] [Abstract][Full Text] [Related]
10. Effects of active non-smoking programmes on smoking behaviour in oral precancer patients.
Hamadah O; Hepburn S; Thomson PJ
Int J Oral Maxillofac Surg; 2007 Aug; 36(8):706-11. PubMed ID: 17448634
[TBL] [Abstract][Full Text] [Related]
11. Effective management of smoking in an oral dysplasia clinic in London.
Poate TW; Warnakulasuriya S
Oral Dis; 2006 Jan; 12(1):22-6. PubMed ID: 16390464
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological factors in early squamous cell carcinoma of the tongue and floor of the mouth, in Biscay (the Basque Country, Spain).
Martínez-Conde R; Aguirre JM; Burgos JJ; Rivera JM
Med Oral; 2001; 6(2):87-94. PubMed ID: 11500624
[TBL] [Abstract][Full Text] [Related]
13. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital.
Hsue SS; Wang WC; Chen CH; Lin CC; Chen YK; Lin LM
J Oral Pathol Med; 2007 Jan; 36(1):25-9. PubMed ID: 17181738
[TBL] [Abstract][Full Text] [Related]
14. [Precancer stages of the oral mucosa: a review].
Dunsche A; Härle F
Laryngorhinootologie; 2000 Jul; 79(7):423-7. PubMed ID: 11005096
[TBL] [Abstract][Full Text] [Related]
15. Squamous cell carcinomas arising from different types of oral epithelia differ in their tumor and patient characteristics and survival.
Rautava J; Luukkaa M; Heikinheimo K; Alin J; Grenman R; Happonen RP
Oral Oncol; 2007 Oct; 43(9):911-9. PubMed ID: 17257885
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of routine follow-up of patients treated for T1-2N0 oral squamous cell carcinomas of the floor of mouth and tongue.
Merkx MA; van Gulick JJ; Marres HA; Kaanders JH; Bruaset I; Verbeek A; de Wilde PC
Head Neck; 2006 Jan; 28(1):1-7. PubMed ID: 16155911
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of relationship between risk factors of malignant transformation of oral leukoplakia and the LSCP system].
Sun Z; Gong Y; Huang J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Sep; 36(5):364-6. PubMed ID: 11769652
[TBL] [Abstract][Full Text] [Related]
18. Malignant transformation of oral epithelial dysplasia: clinicopathological risk factors and outcome analysis in a retrospective cohort of 138 cases.
Liu W; Bao ZX; Shi LJ; Tang GY; Zhou ZT
Histopathology; 2011 Oct; 59(4):733-40. PubMed ID: 21916948
[TBL] [Abstract][Full Text] [Related]
19. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands.
Schepman KP; van der Meij EH; Smeele LE; van der Waal I
Oral Oncol; 1998 Jul; 34(4):270-5. PubMed ID: 9813722
[TBL] [Abstract][Full Text] [Related]
20. Methylation of p16 CpG island associated with malignant progression of oral epithelial dysplasia: a prospective cohort study.
Cao J; Zhou J; Gao Y; Gu L; Meng H; Liu H; Deng D
Clin Cancer Res; 2009 Aug; 15(16):5178-83. PubMed ID: 19671846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
